eEF2/eEF2K Pathway in the Mature Dentate Gyrus Determines Neurogenesis Level and Cognition
CURRENT BIOLOGY
Authors: Taha, Elham; Patil, Sudarshan; Barrera, Iliana; Panov, Julia; Khamaisy, Mohammad; Proud, Christopher G.; Bramham, Clive R.; Rosenblum, Kobi
Abstract
Levels of adult neurogenesis in the dentate gyrus (DG) of the hippocampus are correlated with unique cognitive functions. However, the molecular pathways controlling it are poorly understood. Here, we found that the known physiological ways to enhance neurogenesis converged on the eEF2/eEF2K pathway via AMPK in the DG. Enhancing the elongation phase of mRNA translation in eEF2K-knockout (eEF2K-KO) mice induced the expression of neurogenesis-related proteins in the hippocampus. We thus tested the hypothesis that inducing eEF2K-KO in mature neurons of the DG controls neurogenesis. Indeed, both general eEF2K-KO and targeted KO in DG excitatory mature neurons resulted in enhanced neurogenesis levels and upregulation of neurogenesis-related proteins. Increased neurogenesis was correlated with enhanced performance in DG-dependent learning. Moreover, general and local eEF2K-KO in old mice rejuvenated the DG, paving the way for better mechanistic understanding of how neurogenesis is controlled in the mature DG and possible treatments for incurable aging-associated diseases.
Eukaryotic elongation factor 2 kinase inhibitor, A484954 inhibits noradrenaline-induced acute increase of blood pressure in rats
JOURNAL OF VETERINARY MEDICAL SCIENCE
Authors: Kodama, Tomoko; Okada, Muneyoshi; Yamawaki, Hideyuki
Abstract
Eukaryotic elongation factor 2 (eEF2) kinase (eEF2K) inhibits protein translation through the phosphorylation of its specific substrate, eEF2. We previously demonstrated that eEF2K expression increases in superior mesenteric artery from spontaneously hypertensive rats (SHR) and that eEF2K mediates development of hypertension in SHR. In addition, we recently revealed that A484954, a selective eEF2K inhibitor induced relaxation via opening smooth muscle inward rectifier K+ (K-ir) channel in rat isolated superior mesenteric artery. Here, we further examined the effects of A484954 on contractility and blood pressure (BP) in rats. Isometric contraction of rat isolated superior mesenteric artery was measured. BP was measured by a carotid cannulation method. A484954 (10 mu M) inhibited noradrenaline (NA)-induced contraction in a biphasic manner (magnitude of inhibition higher at high dose NA). A484954 also inhibited an alpha(1)-receptor agonist, phenylephrine-induced contraction, while it was not biphasic. Specifically, a beta-receptor antagonist, propranolol (1 mu M) prevented the A484954-mediated inhibition of NA (high-dose)-induced contraction. A484954 (10 mu M) potentiated a beta-receptor agonist, isoproterenol-induced relaxation, which was completely prevented by BaCl2 (1 mM), a K-ir channel blocker. In vivo, A484954 (122 mu g/kg) inhibited NA-induced increase of BP in rats. Another eEF2K inhibitor, NH125 (22 mu g/kg) also inhibited the NA-induced BP increase in rats. In summary, it was concluded that A484954 lowers NA-induced BP rise perhaps through activation of beta(2)-receptor-K-ir channel and subsequent vasorelaxation via inhibiting eEF2K activity.